

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.82241841 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 6.53372332 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.53372332 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.53372332 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.53372332 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.53372332 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.53372332 |
| 8 | negative regulation of cell killing (GO:0031342) | 6.22955954 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.22955954 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.38971774 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 5.32645784 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.28960456 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 5.14888704 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.13794164 |
| 15 | detection of other organism (GO:0098543) | 5.11061810 |
| 16 | detection of molecule of bacterial origin (GO:0032490) | 4.94662890 |
| 17 | detection of bacterium (GO:0016045) | 4.77774267 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.75911008 |
| 19 | cellular extravasation (GO:0045123) | 4.73524225 |
| 20 | response to peptidoglycan (GO:0032494) | 4.71210864 |
| 21 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.69834343 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.67323753 |
| 23 | detection of external biotic stimulus (GO:0098581) | 4.62314834 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.61931115 |
| 25 | response to host immune response (GO:0052572) | 4.48970491 |
| 26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.48970491 |
| 27 | microglial cell activation (GO:0001774) | 4.48240906 |
| 28 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.42723351 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.35182648 |
| 30 | neutrophil activation (GO:0042119) | 4.30795718 |
| 31 | leukocyte aggregation (GO:0070486) | 4.21626820 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 4.20052905 |
| 33 | respiratory burst (GO:0045730) | 4.13603157 |
| 34 | response to interleukin-15 (GO:0070672) | 4.12401898 |
| 35 | response to host defenses (GO:0052200) | 4.11250002 |
| 36 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.11250002 |
| 37 | response to host (GO:0075136) | 4.11250002 |
| 38 | detection of biotic stimulus (GO:0009595) | 4.06081958 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.04184591 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 4.02393870 |
| 41 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.98778508 |
| 42 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.95374223 |
| 43 | macrophage activation (GO:0042116) | 3.94915291 |
| 44 | neutrophil mediated immunity (GO:0002446) | 3.93895216 |
| 45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.87775793 |
| 46 | cellular response to interleukin-15 (GO:0071350) | 3.83561989 |
| 47 | granulocyte activation (GO:0036230) | 3.83514481 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 3.83273326 |
| 49 | regulation of mast cell degranulation (GO:0043304) | 3.76825756 |
| 50 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.65687102 |
| 51 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.57925035 |
| 52 | positive regulation of mast cell activation (GO:0033005) | 3.57493372 |
| 53 | type I interferon signaling pathway (GO:0060337) | 3.53545100 |
| 54 | cellular response to type I interferon (GO:0071357) | 3.53545100 |
| 55 | immunoglobulin mediated immune response (GO:0016064) | 3.52910035 |
| 56 | response to type I interferon (GO:0034340) | 3.51855998 |
| 57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.50668145 |
| 58 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.47494644 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 3.46969646 |
| 60 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.44191661 |
| 61 | regulation of leukocyte degranulation (GO:0043300) | 3.40811753 |
| 62 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.35357227 |
| 63 | myeloid leukocyte mediated immunity (GO:0002444) | 3.28920493 |
| 64 | response to muramyl dipeptide (GO:0032495) | 3.26340847 |
| 65 | leukocyte degranulation (GO:0043299) | 3.25671808 |
| 66 | regulation of mast cell activation (GO:0033003) | 3.25000503 |
| 67 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.20648989 |
| 68 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.20648989 |
| 69 | negative regulation of type 2 immune response (GO:0002829) | 3.20467983 |
| 70 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.20420045 |
| 71 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.17110697 |
| 72 | germinal center formation (GO:0002467) | 3.15250847 |
| 73 | negative regulation of phagocytosis (GO:0050765) | 3.14862004 |
| 74 | B cell receptor signaling pathway (GO:0050853) | 3.10718478 |
| 75 | regulation of tolerance induction (GO:0002643) | 3.06293824 |
| 76 | regulation of T cell tolerance induction (GO:0002664) | 3.05946237 |
| 77 | positive regulation of mast cell degranulation (GO:0043306) | 3.03451465 |
| 78 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.03451465 |
| 79 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.03437600 |
| 80 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.02111504 |
| 81 | activated T cell proliferation (GO:0050798) | 3.01939204 |
| 82 | regulation of regulated secretory pathway (GO:1903305) | 2.99924161 |
| 83 | defense response to protozoan (GO:0042832) | 2.99358182 |
| 84 | positive regulation of interferon-alpha production (GO:0032727) | 2.96981349 |
| 85 | dendritic cell chemotaxis (GO:0002407) | 2.96139065 |
| 86 | dendritic cell migration (GO:0036336) | 2.95281555 |
| 87 | negative regulation of interleukin-6 production (GO:0032715) | 2.92960024 |
| 88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91717994 |
| 89 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.91695588 |
| 90 | regulation of B cell differentiation (GO:0045577) | 2.90799862 |
| 91 | tolerance induction (GO:0002507) | 2.88584572 |
| 92 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.87741516 |
| 93 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.87459328 |
| 94 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.86674403 |
| 95 | myeloid leukocyte activation (GO:0002274) | 2.85645911 |
| 96 | positive thymic T cell selection (GO:0045059) | 2.85223313 |
| 97 | positive regulation of type 2 immune response (GO:0002830) | 2.85155222 |
| 98 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.83555111 |
| 99 | regulation of type 2 immune response (GO:0002828) | 2.82549960 |
| 100 | neutrophil chemotaxis (GO:0030593) | 2.81902170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.71417285 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.44250901 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.86331608 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.52509965 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.30961293 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.88349243 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.82252396 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.81837379 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79103597 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.70111366 |
| 11 | SPI1_23127762_ChIP-Seq_K562_Human | 2.65443598 |
| 12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.46221887 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40934135 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.31744040 |
| 15 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.29530172 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.28394295 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26312542 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.24959838 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.24915175 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.23861428 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.10008992 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.09867481 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.07671383 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.05961728 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04346180 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.03018357 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.96532552 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.96413970 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93869636 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.91950377 |
| 31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.89198550 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88571129 |
| 33 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.84075896 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.80145291 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78552599 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.71078838 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70993600 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70349319 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66987170 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.64965964 |
| 41 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61595158 |
| 42 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.61481137 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61321748 |
| 44 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.59564848 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.56614548 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54741727 |
| 47 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.53969316 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51127325 |
| 49 | MYC_22102868_ChIP-Seq_BL_Human | 1.50669496 |
| 50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.49038541 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.48073096 |
| 52 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.47770368 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47162273 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43567367 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43381120 |
| 56 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43181625 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40902780 |
| 58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36726186 |
| 59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33450028 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31130121 |
| 61 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26769567 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25854349 |
| 63 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.24496416 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22988306 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21087852 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19970573 |
| 67 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.17549148 |
| 68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17380618 |
| 69 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16399192 |
| 70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15507412 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14155984 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13907936 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12708445 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12456903 |
| 75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10874713 |
| 76 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.10737537 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09165633 |
| 78 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07853363 |
| 79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07362080 |
| 80 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05677322 |
| 81 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03956926 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03086381 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02059363 |
| 84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01084963 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01048137 |
| 86 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00755551 |
| 87 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98985094 |
| 88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95803006 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95398664 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95271207 |
| 91 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94157391 |
| 92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93104584 |
| 93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92936551 |
| 94 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91524585 |
| 95 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88581562 |
| 96 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88444238 |
| 97 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87999844 |
| 98 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87887097 |
| 99 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86943817 |
| 100 | P68_20966046_ChIP-Seq_HELA_Human | 0.86428724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.54169252 |
| 2 | MP0003436_decreased_susceptibility_to | 4.24761584 |
| 3 | MP0003303_peritoneal_inflammation | 3.85526647 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.54823372 |
| 5 | MP0002419_abnormal_innate_immunity | 3.19632795 |
| 6 | MP0005025_abnormal_response_to | 2.82682046 |
| 7 | MP0005671_abnormal_response_to | 2.71601600 |
| 8 | MP0001800_abnormal_humoral_immune | 2.70808130 |
| 9 | MP0009785_altered_susceptibility_to | 2.63868155 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.61278007 |
| 11 | MP0001790_abnormal_immune_system | 2.59804704 |
| 12 | MP0005387_immune_system_phenotype | 2.59804704 |
| 13 | MP0000685_abnormal_immune_system | 2.57643780 |
| 14 | MP0006082_CNS_inflammation | 2.55481195 |
| 15 | MP0002723_abnormal_immune_serum | 2.46938162 |
| 16 | MP0002132_abnormal_respiratory_system | 2.46331227 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.41935847 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.38524336 |
| 19 | MP0001819_abnormal_immune_cell | 2.36050817 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.32111888 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.31484976 |
| 22 | MP0005377_hearing/vestibular/ear_phenot | 2.16815805 |
| 23 | MP0003878_abnormal_ear_physiology | 2.16815805 |
| 24 | MP0008260_abnormal_autophagy | 2.12032431 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.08092131 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.01829800 |
| 27 | MP0002405_respiratory_system_inflammati | 1.96701716 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.92767977 |
| 29 | MP0009278_abnormal_bone_marrow | 1.86782326 |
| 30 | MP0005451_abnormal_body_composition | 1.84731934 |
| 31 | MP0003828_pulmonary_edema | 1.77250117 |
| 32 | MP0002398_abnormal_bone_marrow | 1.75870605 |
| 33 | MP0000716_abnormal_immune_system | 1.73643145 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.72731122 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.71807931 |
| 36 | MP0005310_abnormal_salivary_gland | 1.57186048 |
| 37 | MP0003866_abnormal_defecation | 1.57087337 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.57060937 |
| 39 | MP0009764_decreased_sensitivity_to | 1.56167272 |
| 40 | MP0004947_skin_inflammation | 1.53100953 |
| 41 | MP0003690_abnormal_glial_cell | 1.52532777 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.51526878 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.50552862 |
| 44 | MP0004883_abnormal_blood_vessel | 1.49225221 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.47038716 |
| 46 | MP0004510_myositis | 1.46935712 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.43112917 |
| 48 | MP0005410_abnormal_fertilization | 1.42793342 |
| 49 | MP0002722_abnormal_immune_system | 1.42531172 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.39197797 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.38204759 |
| 52 | MP0003075_altered_response_to | 1.36343935 |
| 53 | MP0002429_abnormal_blood_cell | 1.32527525 |
| 54 | MP0008469_abnormal_protein_level | 1.31690459 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.30850842 |
| 56 | MP0001851_eye_inflammation | 1.27525250 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.26731648 |
| 58 | MP0004381_abnormal_hair_follicle | 1.22705544 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.20740342 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.20740342 |
| 61 | MP0005164_abnormal_response_to | 1.15997615 |
| 62 | MP0008004_abnormal_stomach_pH | 1.14994473 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.11075458 |
| 64 | MP0005166_decreased_susceptibility_to | 1.08925131 |
| 65 | MP0000858_altered_metastatic_potential | 1.06260108 |
| 66 | MP0005390_skeleton_phenotype | 1.05074567 |
| 67 | MP0003879_abnormal_hair_cell | 0.99900046 |
| 68 | MP0001958_emphysema | 0.99285183 |
| 69 | MP0000604_amyloidosis | 0.93426731 |
| 70 | MP0003448_altered_tumor_morphology | 0.85053632 |
| 71 | MP0003045_fibrosis | 0.84976594 |
| 72 | MP0002653_abnormal_ependyma_morphology | 0.84116804 |
| 73 | MP0000343_altered_response_to | 0.83455088 |
| 74 | MP0003329_amyloid_beta_deposits | 0.82094252 |
| 75 | MP0005248_abnormal_Harderian_gland | 0.80632792 |
| 76 | MP0001986_abnormal_taste_sensitivity | 0.80477703 |
| 77 | MP0001663_abnormal_digestive_system | 0.74427577 |
| 78 | MP0008874_decreased_physiological_sensi | 0.73743754 |
| 79 | MP0002928_abnormal_bile_duct | 0.71166643 |
| 80 | MP0009763_increased_sensitivity_to | 0.70389539 |
| 81 | MP0000249_abnormal_blood_vessel | 0.70233768 |
| 82 | MP0005083_abnormal_biliary_tract | 0.68810885 |
| 83 | MP0000920_abnormal_myelination | 0.66905792 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.65536401 |
| 85 | MP0005388_respiratory_system_phenotype | 0.64486831 |
| 86 | MP0002133_abnormal_respiratory_system | 0.64486831 |
| 87 | MP0001853_heart_inflammation | 0.63580694 |
| 88 | MP0002166_altered_tumor_susceptibility | 0.63458021 |
| 89 | MP0002933_joint_inflammation | 0.61429750 |
| 90 | MP0005075_abnormal_melanosome_morpholog | 0.60024698 |
| 91 | MP0004858_abnormal_nervous_system | 0.59581716 |
| 92 | MP0003795_abnormal_bone_structure | 0.58878667 |
| 93 | MP0004130_abnormal_muscle_cell | 0.58804181 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.56952708 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.55938262 |
| 96 | MP0004808_abnormal_hematopoietic_stem | 0.54197873 |
| 97 | MP0005058_abnormal_lysosome_morphology | 0.53932902 |
| 98 | MP0003091_abnormal_cell_migration | 0.52489411 |
| 99 | MP0004484_altered_response_of | 0.52426892 |
| 100 | MP0009115_abnormal_fat_cell | 0.51528792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.79003602 |
| 2 | Myositis (HP:0100614) | 6.02679368 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.98144051 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.87641359 |
| 5 | Orchitis (HP:0100796) | 5.83582164 |
| 6 | Optic neuritis (HP:0100653) | 5.46638065 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.46638065 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.44259935 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.11451900 |
| 10 | Stomatitis (HP:0010280) | 4.78399228 |
| 11 | Hypochromic microcytic anemia (HP:0004840) | 4.74705021 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.65239376 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 4.62185993 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 4.24879030 |
| 15 | Obstructive lung disease (HP:0006536) | 4.24879030 |
| 16 | Increased IgE level (HP:0003212) | 3.97866742 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.96513936 |
| 18 | Gingivitis (HP:0000230) | 3.96395050 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.95747150 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.90145839 |
| 21 | Meningitis (HP:0001287) | 3.88239892 |
| 22 | Spontaneous hematomas (HP:0007420) | 3.84269373 |
| 23 | Recurrent skin infections (HP:0001581) | 3.81165326 |
| 24 | Peritonitis (HP:0002586) | 3.76575449 |
| 25 | Hypochromic anemia (HP:0001931) | 3.65767725 |
| 26 | Encephalitis (HP:0002383) | 3.61014449 |
| 27 | Prolonged bleeding time (HP:0003010) | 3.59670401 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.57219295 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.53270846 |
| 30 | Urticaria (HP:0001025) | 3.32117299 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.31860440 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 3.31860440 |
| 33 | Vasculitis (HP:0002633) | 3.29125161 |
| 34 | Chest pain (HP:0100749) | 3.23609180 |
| 35 | Episodic fever (HP:0001954) | 3.21448725 |
| 36 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.20382413 |
| 37 | Cellulitis (HP:0100658) | 3.17881570 |
| 38 | Gingival bleeding (HP:0000225) | 3.06492973 |
| 39 | Hemoptysis (HP:0002105) | 2.98336335 |
| 40 | Amyloidosis (HP:0011034) | 2.84423960 |
| 41 | Arterial thrombosis (HP:0004420) | 2.80648419 |
| 42 | Leukocytosis (HP:0001974) | 2.79219631 |
| 43 | Nasal polyposis (HP:0100582) | 2.75325663 |
| 44 | Epistaxis (HP:0000421) | 2.74644220 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.72460504 |
| 46 | T lymphocytopenia (HP:0005403) | 2.70645416 |
| 47 | Microcytic anemia (HP:0001935) | 2.66729549 |
| 48 | Pulmonary embolism (HP:0002204) | 2.66195866 |
| 49 | Petechiae (HP:0000967) | 2.64550580 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.61693005 |
| 51 | Anorexia (HP:0002039) | 2.60210338 |
| 52 | Abnormality of T cell number (HP:0011839) | 2.58698076 |
| 53 | Increased IgM level (HP:0003496) | 2.55812367 |
| 54 | Abnormality of the peritoneum (HP:0002585) | 2.55729837 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.52384248 |
| 56 | Purpura (HP:0000979) | 2.39702301 |
| 57 | Slow saccadic eye movements (HP:0000514) | 2.31252046 |
| 58 | Osteomyelitis (HP:0002754) | 2.29738795 |
| 59 | Abnormality of the nasal mucosa (HP:0000433) | 2.29235958 |
| 60 | Abnormal platelet volume (HP:0011876) | 2.27225966 |
| 61 | Abnormality of T cells (HP:0002843) | 2.25347075 |
| 62 | Sepsis (HP:0100806) | 2.23783390 |
| 63 | Granulocytopenia (HP:0001913) | 2.22600087 |
| 64 | Hypergammaglobulinemia (HP:0010702) | 2.22459752 |
| 65 | Abnormality of the pleura (HP:0002103) | 2.21175699 |
| 66 | Vertigo (HP:0002321) | 2.16020479 |
| 67 | Glomerulopathy (HP:0100820) | 2.14287943 |
| 68 | Recurrent viral infections (HP:0004429) | 2.13516543 |
| 69 | Recurrent pneumonia (HP:0006532) | 2.11503602 |
| 70 | Gangrene (HP:0100758) | 2.09376964 |
| 71 | Abnormality of the endocardium (HP:0004306) | 2.09360540 |
| 72 | Pustule (HP:0200039) | 2.08253697 |
| 73 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.06174263 |
| 74 | Lymphopenia (HP:0001888) | 2.03780762 |
| 75 | Acne (HP:0001061) | 2.02573117 |
| 76 | Panhypogammaglobulinemia (HP:0003139) | 2.01418671 |
| 77 | Acute hepatic failure (HP:0006554) | 2.00688219 |
| 78 | Abnormality of the pericardium (HP:0001697) | 1.99653969 |
| 79 | Severe visual impairment (HP:0001141) | 1.99422448 |
| 80 | Hepatosplenomegaly (HP:0001433) | 1.95308148 |
| 81 | Polycythemia (HP:0001901) | 1.93257493 |
| 82 | Toxemia of pregnancy (HP:0100603) | 1.89393010 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89063787 |
| 84 | Postural instability (HP:0002172) | 1.88416181 |
| 85 | Abnormality of T cell physiology (HP:0011840) | 1.87695807 |
| 86 | Asymmetric septal hypertrophy (HP:0001670) | 1.86312708 |
| 87 | Skin ulcer (HP:0200042) | 1.85930730 |
| 88 | Eosinophilia (HP:0001880) | 1.85810208 |
| 89 | Chronic otitis media (HP:0000389) | 1.85358675 |
| 90 | Papilledema (HP:0001085) | 1.83888735 |
| 91 | Recurrent lower respiratory tract infections (HP:0002783) | 1.83159801 |
| 92 | Colitis (HP:0002583) | 1.82461619 |
| 93 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.82229713 |
| 94 | Keratitis (HP:0000491) | 1.81417677 |
| 95 | Difficulty running (HP:0009046) | 1.78127116 |
| 96 | Metaphyseal cupping (HP:0003021) | 1.77588268 |
| 97 | Loss of speech (HP:0002371) | 1.77378817 |
| 98 | Premature loss of primary teeth (HP:0006323) | 1.76995358 |
| 99 | Recurrent sinusitis (HP:0011108) | 1.75199605 |
| 100 | Recurrent bronchitis (HP:0002837) | 1.72891002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.17855693 |
| 2 | BLK | 3.27276734 |
| 3 | IRAK4 | 3.16654187 |
| 4 | MAP4K1 | 3.08544838 |
| 5 | MAP2K3 | 2.89331238 |
| 6 | TYK2 | 2.68907890 |
| 7 | CSK | 2.66958892 |
| 8 | ERN1 | 2.64698330 |
| 9 | TNK2 | 2.48684823 |
| 10 | EPHB1 | 2.47354542 |
| 11 | FES | 2.40912764 |
| 12 | GRK6 | 2.23000622 |
| 13 | ZAP70 | 1.88752240 |
| 14 | PRPF4B | 1.87157293 |
| 15 | TAOK1 | 1.85179565 |
| 16 | MAP3K11 | 1.80226460 |
| 17 | HCK | 1.76209974 |
| 18 | JAK3 | 1.70874763 |
| 19 | MAP3K3 | 1.70043222 |
| 20 | KSR2 | 1.68046294 |
| 21 | BTK | 1.63416281 |
| 22 | FGR | 1.62757553 |
| 23 | TXK | 1.53853525 |
| 24 | SYK | 1.50278223 |
| 25 | JAK2 | 1.47431742 |
| 26 | MARK2 | 1.37668265 |
| 27 | MAP3K1 | 1.33013973 |
| 28 | IKBKE | 1.31422787 |
| 29 | LYN | 1.25886040 |
| 30 | JAK1 | 1.19434719 |
| 31 | YES1 | 1.16506282 |
| 32 | STK38 | 1.16125823 |
| 33 | PTK2B | 1.14397101 |
| 34 | PIK3CG | 1.14040883 |
| 35 | PRKD2 | 1.12289159 |
| 36 | PDK1 | 1.10615746 |
| 37 | TBK1 | 1.07416065 |
| 38 | KIT | 1.07083545 |
| 39 | CDK19 | 1.04554813 |
| 40 | IRAK1 | 1.04377269 |
| 41 | PDPK1 | 1.01118525 |
| 42 | LCK | 1.00780104 |
| 43 | CSF1R | 0.97935767 |
| 44 | SIK2 | 0.97273074 |
| 45 | IRAK2 | 0.96672462 |
| 46 | PTK6 | 0.95452503 |
| 47 | DYRK1B | 0.91058763 |
| 48 | MAP3K14 | 0.87235658 |
| 49 | BMPR2 | 0.85791693 |
| 50 | ITK | 0.84542441 |
| 51 | MAP3K2 | 0.83261611 |
| 52 | SMG1 | 0.83068733 |
| 53 | TAOK3 | 0.81197720 |
| 54 | MATK | 0.80315926 |
| 55 | MARK3 | 0.80166371 |
| 56 | MAP3K7 | 0.80025418 |
| 57 | MAP3K6 | 0.79653143 |
| 58 | MAP3K13 | 0.79450844 |
| 59 | SIK3 | 0.78700324 |
| 60 | TEC | 0.75591006 |
| 61 | MAP2K4 | 0.75283108 |
| 62 | TRIB3 | 0.74475385 |
| 63 | TAOK2 | 0.71688744 |
| 64 | FYN | 0.70907339 |
| 65 | STK11 | 0.66262431 |
| 66 | SGK3 | 0.64774262 |
| 67 | TESK2 | 0.63262790 |
| 68 | BRD4 | 0.62551804 |
| 69 | STK10 | 0.61884907 |
| 70 | WNK1 | 0.60018964 |
| 71 | DAPK2 | 0.58692001 |
| 72 | EPHA3 | 0.58591949 |
| 73 | RPS6KL1 | 0.58201615 |
| 74 | RPS6KC1 | 0.58201615 |
| 75 | SGK2 | 0.57720937 |
| 76 | MAPK12 | 0.56306498 |
| 77 | MAPK7 | 0.56089169 |
| 78 | RET | 0.55407687 |
| 79 | PRKG2 | 0.55086941 |
| 80 | FGFR3 | 0.54241156 |
| 81 | CDC42BPA | 0.50984670 |
| 82 | RPS6KA6 | 0.49589741 |
| 83 | IKBKB | 0.49237089 |
| 84 | TGFBR2 | 0.49131362 |
| 85 | PLK4 | 0.47413236 |
| 86 | RAF1 | 0.46683202 |
| 87 | LRRK2 | 0.46137371 |
| 88 | PRKCZ | 0.45825589 |
| 89 | FGFR4 | 0.45156200 |
| 90 | MAP3K5 | 0.44764000 |
| 91 | PRKCQ | 0.44721601 |
| 92 | HIPK2 | 0.44009882 |
| 93 | NLK | 0.43583339 |
| 94 | SIK1 | 0.41402390 |
| 95 | SGK494 | 0.40446145 |
| 96 | SGK223 | 0.40446145 |
| 97 | CAMK4 | 0.37880102 |
| 98 | GRK7 | 0.36806340 |
| 99 | CAMK1 | 0.35948238 |
| 100 | RPS6KA2 | 0.35051191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.04951103 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.87721506 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.71651105 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.26600824 |
| 5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.25848478 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.13518119 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.09670912 |
| 8 | Malaria_Homo sapiens_hsa05144 | 2.07044322 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.98769091 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.92551928 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89657711 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.80231633 |
| 13 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.78720469 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74307457 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.70749228 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.68105962 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.66324674 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.64130593 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.60704241 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53030922 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.45681620 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.44524263 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.43994554 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43211826 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.43096479 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.41275346 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40936320 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39636974 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.38529465 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33954726 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33704704 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31788691 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27705716 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25828375 |
| 35 | Platelet activation_Homo sapiens_hsa04611 | 1.24324215 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.21397113 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15898950 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15504927 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14696690 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08679760 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.07468375 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.04222141 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.03699260 |
| 44 | Endocytosis_Homo sapiens_hsa04144 | 0.99757277 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97334248 |
| 46 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92278721 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91667133 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 0.87740754 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86043947 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85063415 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82858527 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82556265 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81944073 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81710984 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.81562568 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81536770 |
| 57 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.81252665 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80880508 |
| 59 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79735765 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79668119 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78609786 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78442918 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78196010 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 0.78161314 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77441437 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.74128336 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70695057 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69843011 |
| 69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69337831 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69055856 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68241104 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68019930 |
| 73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67832570 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67469121 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.66629095 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66541991 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64692600 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61033004 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60574657 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59736591 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57890726 |
| 82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.57716437 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55994235 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.54885888 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53065638 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52756125 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50849967 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50058923 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49549376 |
| 90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49007207 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48991771 |
| 92 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.47621235 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.47329025 |
| 94 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47081140 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46865145 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.46719520 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45430583 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.45382864 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44856332 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44767225 |

